In Re Diet Drugs Products Liability Litigation

90 F. App'x 643
CourtCourt of Appeals for the Third Circuit
DecidedFebruary 18, 2004
Docket02-4613, 02-4616, 03-1006
StatusUnpublished
Cited by2 cases

This text of 90 F. App'x 643 (In Re Diet Drugs Products Liability Litigation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Diet Drugs Products Liability Litigation, 90 F. App'x 643 (3d Cir. 2004).

Opinion

OPINION

AMBRO, Circuit Judge.

Class members who had previously settled their mass tort class actions appeal the District Court’s Pretrial Order No. 2663 (PTO 2663) suspending claim processing deadlines contained in a court-approved settlement agreement. Because we conclude that the District Court acted within its discretion, we affirm.

I. Factual Background

The original class action involved two diet drugs of American Home Products Corporation (“AHP”), 1 Pondimin and Re-dux (fenfluramine and dexfenfluramine, respectively). Approximately four million people took Pondimin and two million took Redux before AHP removed the diet drugs from the market in 1997 after they were found to be associated with valvular heart disease (“VHD”). In November 1999, plaintiffs and AHP executed the Nation *645 wide Class Action Settlement Agreement (the “Settlement Agreement”). 2

The Settlement Agreement created two separate funds. A smaller fund (Fund A) was to pay for echocardiogram screening costs, additional medical services to monitor VHD, and reimbursement of diet drug prescriptions. A larger one (Fund B) was created to compensate class members for their injuries. In September 2000, the AHP Settlement Trust (the “Trust”) was created to administer the claims and payments of benefits to class members.

The Settlement Agreement prescribes certain time periods within which the Trust’s various claims processing functions must be completed. For example, the Trust has 30 days from the receipt of a claim for assigning a claim number and notifying the claimant of that number, determining whether the claimant needs to submit additional information and informing the claimant of it, and confirming the qualifications of any attesting physician. Furthermore, the Trust must, within 45 days from receiving a completed claim, determine whether the claimant is eligible for various benefits under the Settlement Agreement. The Trust was unable to meet these deadlines.

The Settlement Agreement also provides that “[a]t any time, the Court may extend any [relevant] time period for good cause shown upon application by the Parties, Trustees, Claims Administrators(s), ..., after notice to AHP and Class Counsel.” Based on this provision, the Trust moved the District Court for suspension of processing deadlines. The Trust claimed that it could not meet the deadlines because it experienced an unexpectedly high volume of claims. It also argued that it was overwhelmed with claims that lacked essential information such as claimants’ names, signatures, or allegations of diet drug use. 3 On December 3, 2002, upon finding that the Trust showed good cause for the delay, the District Court, in PTO 2663, suspended deadlines for five months. 4 The District Court noted that the deadlines would be automatically reinstated on May 1, 2003. Class members appeal the District Court’s order.

II. Jurisdiction

The Trust challenges our jurisdiction, arguing that the District Court’s order is not final under 28 U.S.C. § 1291. We disagree. While hardly every pretrial order in the Diet Drug cases is final, this one is.

The only issue before the District Court was whether the Trust was allowed to extend deadlines for processing claims. Contrary to the Trust’s suggestion, claims for settlement benefits are not in dispute and no other order merges with PTO 2663. As there are no other issues left to be disposed, appeal of the District Court’s order would not result in delay. See Bachowski v. Usery, 545 F.2d 363, 368 (3d Cir.1976) (“The hostility towards piecemeal appeals expressed by the final judgment rule has a strong basis in logic and practicality. Forbidding appeals from all interlocutory judgments of the district courts achieves significant savings in time and resources on the part of litigants and courts. This is so since if litigation proceeds, the intermediate ruling may lose its *646 significance (citing Radio Station WOW v. Johnson, 326 U.S. 120, 123-24, 65 S.Ct. 1475, 89 L.Ed. 569 (1945); 15 C. Wright, A. Miller & E. Cooper, Federal Practice and Procedure § 3907 (1976)). In sum, the order in question was as final as it gets; it was the determination of the only issue that was before the District Court and, therefore, is appealable under § 1291. 5

III. Standard of Review

When the “[stipulation [of the parties] places into the District Court’s jurisdiction ongoing authority over the Settlement, ... with that comes the discretion necessary to exercise jurisdiction.” In re Cendant Corp. Prides Litigation, 233 F.3d 188, 194 (3d Cir.2000). In this case, the Settlement Agreement provides that “the Court may extend any [relevant] time period for good cause shown upon application by the Parties, Trustees, Claims Administrators(s)----” Thus, we review the District Court’s order to extend the deadlines for abuse of discretion. Our review of the admissibility of evidence is also for abuse of discretion. In re Merritt Logan, Inc., 901 F.2d 349, 359 (3d Cir.1990).

YI. Discussion

A.

Class members argue that the Trust did not show good cause to extend the time period. They contend that the District Court impermissibly rewrote the Settlement Agreement by finding good cause for the delay and ordering suspension of deadlines. We disagree.

The District Court concluded that good cause was shown for extension of deadlines because it found that the delay resulted from unforeseen factors. The Court first noted that the Trust received an unexpectedly high number of claims, far out of proportion with the projections on which the Settlement Agreement was based. The District Court also pointed out that tens of thousands of incomplete claim forms were filed, which also contributed to the significant delay in processing time.

Class members do not dispute any pertinent findings by the District Court. However, they assert that the claims processing delay was also due to the incompetence of a contractor the Trust hired. Thus they contend that the District Court erred because it did not in its order mention the fact that the Trust itself also contributed to the delay.

Because our review is for abuse of discretion, we will reverse if “the district court’s decision rests upon a clearly erroneous finding of fact, an errant conclusion of law, or an improper application of law to fact.” Int’l Union, United Auto., Aerospace and Agric. Implement Workers of Am., UAW v. Mack Trucks, Inc.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
90 F. App'x 643, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-diet-drugs-products-liability-litigation-ca3-2004.